|
MechanismTGF-β inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Clavius Pharmaceuticals, LLC
0 Patents (Medical) associated with Clavius Pharmaceuticals, LLC
100 Deals associated with Clavius Pharmaceuticals, LLC
100 Translational Medicine associated with Clavius Pharmaceuticals, LLC